Drugmaker Johnson & Johnson (NYSE: JNJ) announced a $10 billion stock buyback program today (Tuesday) amid a mixed Q3 earnings...
Over the past few weeks, one "clinical stage" pharma firm after another has seen its stock price rise and plummet on rumors about who has the...
A burst of mergers and acquisitions dominated today's stock market news.
M&A activity year-to-date, driven by healthcare,...
Dividend Aristocrats are an exceptional bunch of S&P 500 companies that don't just offer high yield – they have increased shareholders' payouts...
The stock market today opened higher as earnings continue to be "not...
If you looked at just the first-quarter results you could be forgiven for thinking that everything in the stock market is rosy. The
